Discover the latest insights in the "Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, 2025." This comprehensive report details RSV clinical trial data, including trial ...

Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract ...

Vaccinating pregnant women against respiratory syncytial virus (RSV) is linked to a 72% drop in newborns being hospitalized ...

Increases in COVID, RSV, and influenza are the result of governments refusal to enact public health measures and address ...

Pregnant individuals commonly reported hesitancy toward RSVpreF and nirsevimab, indicating the need for efforts to promote the safety and uptake of RSV immunization.

AI has become a critical tool in diagnosing and managing viral infections such as influenza, respiratory syncytial virus (RSV ...

Many viruses circulate seasonally, picking up as the weather cools in the fall and winter. So it's true that fewer people get stuffy noses and coughs in the summer — but cold weather itself does not ...

Children hospitalized with RSV showed higher risk for ICU admission, IMV, and supplemental oxygen than children hospitalized with COVID-19 or influenza.

A NEW vaccine to protect against a serious respiratory infection is now being offered on the high street. 60 community pharmacies across Cheshire, Merseyside, Lancashire and South Cumbria are now ...

UKHSA study shows RSV vaccine highly effective in preventing hospitalisation: United Kingdom Saturday, August 2, 2025, 10:00 Hrs [IST] A new UK Health Security Agency study - Effe ...

The investigators noted cardiovascular events for up to 1 year post-discharge in 18.5% of RSV patients, compared with 17.7% ...

RSV vaccines are 82% effective for older people and 72% for newborns when mothers are vaccinated at least 14 days before ...